Health and Pharmaceutical Press Releases - Interfax Newswire

Health and Pharmaceutical Press Releases

2015-11-19 10:18 Merck and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma

2015-11-18 14:44 India’s Leading Maternity and Birthing Care Hospital Group, Cloudnine, Adopts Masimo SET® Technology to Screen Infants for CCHD

2015-11-18 14:30 Pharco Pharmaceuticals Inc. Reports Ravidasvir Achieved 100% Cure Rate to Date When Combined with Sofosbuvir for HCV, Non-Cirrhotic, Genotype 4 Patients

2015-11-18 09:42 GORE® EXCLUDER® Iliac Branch Endoprosthesis Exceeds 1,000 Implants Worldwide

2015-11-18 09:25 Gore Achieves 40 Million Implants Sold Worldwide as it Celebrates 40 Years of Performance

2015-11-17 15:16 Time is of the Essence for Millions Living with ‘Neglected’ Lung Disease: Your Time Campaign Calls for Earlier Action in COPD

2015-11-17 10:13 Replicor Discloses Continued Improvement of the Antiviral Response in Patients with HBV / HDV Co-Infection Receiving REP 2139-Ca Based Combination Therapy

2015-11-16 09:54 New Analyses Further Add to the Efficacy and Safety Profile of OFEV® (nintedanib) in Idiopathic Pulmonary Fibrosis (IPF)

2015-11-13 16:12 In New Study EMMA™ Capnograph Has Comparable Accuracy to Sidestream Capnography Against Gold-Standard Blood Gas Analysis

2015-11-12 17:08 Taiyo Pacific Partners Becomes Major Shareholder in JIN Co., Ltd. with Stake over 5%

2015-11-12 15:48 New Dimension of Natural Beauty in Hong Kong

2015-11-12 15:33 Replicor Announces Publication of Its Pre-Clinical Data on the Therapeutic Effect of NAPs on Hepatitis B Virus Infection.

2015-11-12 10:42 Boehringer Ingelheim Will Invest 11 Billion Euros in Research and Development in the Next Five Years to Accelerate the Discovery of Next Generation Medical Breakthroughs

2015-11-11 16:45 C2 Therapeutics Announces New Data Confirming Efficacy and Safety of Coldplay CryoBalloon® Focal Ablation System to Treat Esophageal Disease

2015-11-11 10:00 Boehringer Ingelheim Announces Completed Enrollment of Phase III Clinical Trial for Biosimilar Candidate to Adalimumab

2015-11-11 09:54 Boehringer Ingelheim partners with leading scientific institutions in inflammatory bowel disease research

2015-11-10 16:27 Real-World Analysis of more than 44,000 Patients Reinforces Safety and Effectiveness of Pradaxa® in Routine Clinical Care

2015-11-10 16:10 Boehringer Ingelheim Presents New idarucizumab (Praxbind®) Analyses on Reintroduction of Antithrombotic Therapy after Reversal of Dabigatran

2015-11-10 15:54 Quintiles Contributes Open Source Code to ResearchKit

2015-11-10 11:12 Allianz Worldwide Care Named ‘Best International Private Health Insurance Provider’ at Industry Awards

Shanghai

Rm 703 Pan Pacific Tower, No. 1250 West Beijing Rd, Shanghai, China

+86 21 5239 8905

press@interfax.cn

Hong Kong

21-22/F, One Pacific Centre
414 Kwun Tong Road
Kowloon, Hong Kong

+852-2537 2262

press@interfax.cn

© 2008-2026 Interfax News Service Limited, all rights reserved.
Operated by Interfax News Service Limited, an independent company and an authorized distribution partner of Business Wire, Inc. Business Wire[®] is a [registered] trademark of Business Wire, Inc. Interfax News Service Limited is not an agent, partner or joint venturer of Business Wire, Inc.